Quinax is a remedy for the treatment of cataracts. It activates the proteolytic enzymes of the moisture of the anterior chamber of the eyes, due to which the resorption of opaque proteins of the lens is possible. Provides protection of sulfhydryl compounds of the lens from the action of oxidative reactions.
Quinax (Quinax) method of administration and doses:
Quinax is instilled 1-2 drops into the affected eye 3-5 times a day. The product is intended for continuous use only. In the event of a rapid therapeutic effect, Quinax therapy is not recommended to be interrupted.
Strictly controlled and adequate clinical studies confirming the safety of using Quinax during pregnancy and breastfeeding have not been conducted – it is not recommended to prescribe a remedy for these categories of patients.
Use with other medicinal products:
Quinax (Quinax) composition:
Active substance (in 1 ml): azapentacene (sodium dihydroazapentacene polysulfonate) – 150 mcg.
Inactive substances: boric acid, propylparaben, methylparaben, thimersal, distilled water.
It is not recommended to wear contact lenses while using Quinax. The solution is not intended for parenteral administration. During instillation, contact of the pipette with any surface should be avoided to prevent microbial contamination.
It is possible to prescribe the product to children – if the expected therapeutic effect exceeds the potential risk of side effects (adequate and strictly controlled studies on the safety of Quinax in children have not been conducted).
It is not recommended to engage in activities that require clarity of vision if visual impairment is observed after instillation (for example, driving a car, operating complex equipment).